Stoschitzky K, Kahr S, Donnerer J, Schumacher M, Luha O, Maier R, Klein W, Lindner W
Department of Medicine/Division of Cardiology, Karl Franzens University, Graz, Austria.
Clin Pharmacol Ther. 1995 May;57(5):543-51. doi: 10.1016/0009-9236(95)90039-X.
In vitro studies have shown that, like catecholamines, both propranolol and atenolol are taken up by and released from adrenergic cells. We performed this study to investigate whether this may also play a role in humans and whether stereoselective aspects are important.
This was a randomized, double-blind, placebo-controlled, crossover study of two groups of 12 healthy volunteers. Subjects received single oral doses of 80 mg (R,S)-, 40 mg (R)-, and 40 mg (S)-propranolol; 100 mg (R,S)-, 50 mg (R)-, and 50 mg (S)-atenolol; and placebo at intervals of 1 week. Exercise was performed at 4 and 9 hours after drug intake, and blood samples were taken before and at the end of each exercise period. The plasma concentrations of the (R)- and (S)-enantiomers of propranolol and atenolol, as well as those of epinephrine and norepinephrine, were determined by HPLC.
Effects of exercise on the plasma levels of the enantiomers of propranolol and atenolol were similar. When the optically pure enantiomers were administered, exercise caused a marked and significant increase of the plasma concentrations of the (S)- but not of the (R)-enantiomers. When the drugs were administered in the racemic form, the plasma levels of both the (R)- and (S)-enantiomers were elevated to the same extent. The increase of norepinephrine levels during exercise was more pronounced than that of epinephrine and paralleled that of the (S)-enantiomers of the beta-blockers.
Bearing the in vitro data in mind, we conclude that (S)-propranolol and (S)-atenolol are taken up into and released from adrenergic cells together with norepinephrine during exercise. The reason why the plasma concentrations of (R)-propranolol and (R)-atenolol are increased only during exercise in the presence of the corresponding (S)-enantiomers remains to be determined.
体外研究表明,普萘洛尔和阿替洛尔与儿茶酚胺一样,可被肾上腺素能细胞摄取并释放。我们开展本研究以调查这在人体中是否也起作用以及立体选择性方面是否重要。
这是一项针对两组各12名健康志愿者的随机、双盲、安慰剂对照、交叉研究。受试者每隔1周接受单次口服剂量的80毫克(R,S)-、40毫克(R)-和40毫克(S)-普萘洛尔;100毫克(R,S)-、50毫克(R)-和50毫克(S)-阿替洛尔;以及安慰剂。在服药后4小时和9小时进行运动,并在每个运动时段开始前和结束时采集血样。通过高效液相色谱法测定普萘洛尔和阿替洛尔的(R)-和(S)-对映体以及肾上腺素和去甲肾上腺素的血浆浓度。
运动对普萘洛尔和阿替洛尔对映体血浆水平的影响相似。给予光学纯对映体时,运动导致(S)-对映体而非(R)-对映体的血浆浓度显著升高。当以消旋形式给药时,(R)-和(S)-对映体的血浆水平升高幅度相同。运动期间去甲肾上腺素水平的升高比肾上腺素更明显,且与β受体阻滞剂的(S)-对映体平行。
考虑到体外数据,我们得出结论,运动期间(S)-普萘洛尔和(S)-阿替洛尔与去甲肾上腺素一起被肾上腺素能细胞摄取并释放。(R)-普萘洛尔和(R)-阿替洛尔的血浆浓度仅在相应(S)-对映体存在时运动期间升高的原因尚待确定。